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Abstract: Two bioactive compounds, quercetin and ferulic acid, were encapsulated using the 
electrospinning technique within hybrid amaranth protein isolate (API):pullulan ultrathin fibres. 
Initially, the composition of the encapsulation structures was optimized, both in terms of matrix 
components ratio and to maximize the bioactive loading. The morphology and thermal stability of the 
developed encapsulation structures were evaluated, as well as the encapsulation efficiency and 
distribution within the fibres of both antioxidant compounds. Moreover, the release characteristics and 
protection ability of the encapsulation structures during an in-vitro digestion study were investigated. 
Smooth ultrathin electrospun fibres were obtained in which the antioxidants were homogeneously 
distributed. Through this methodology, it was possible to incorporate within the API:pullulan fibres up 
to 10 and 20 % (by weight) of quercetin and ferulic acid, respectively, which were released in a 
sustained manner during in-vitro digestion, keeping to a greater extent their antioxidant capacity in 
comparison with the non-encapsulated compounds. 
 
 
 
 
HIGHLIGHTS 
 Quercetin and ferulic acid were encapsulated using electrospinning 
 Blends of amaranth protein isolate and pullulan were used as encapsulating 
matrices 
 Sustained release of the antioxidants from the electrospun fibers was observed 
 Encapsulation improved antioxidant capacity of bioactives during in-vitro 
digestion 
*Highlights (for review)
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Abstract 
Two bioactive compounds, quercetin and ferulic acid, were encapsulated using the 
electrospinning technique within hybrid amaranth protein isolate (API):pullulan 
ultrathin fibres. Initially, the composition of the encapsulation structures was optimized, 
both in terms of matrix components ratio and to maximize the bioactive loading. The 
morphology and thermal stability of the developed encapsulation structures were 
evaluated, as well as the encapsulation efficiency and distribution within the fibres of 
both antioxidant compounds. Moreover, the release characteristics and protection ability 
of the encapsulation structures during an in-vitro digestion study were investigated. 
Smooth ultrathin electrospun fibres were obtained in which the antioxidants were 
homogeneously distributed. Through this methodology, it was possible to incorporate 
within the API:pullulan fibres up to 10 and 20 % (by weight) of quercetin and ferulic 
acid, respectively, which were released in a sustained manner during in-vitro digestion, 
keeping to a greater extent their antioxidant capacity in comparison with the non-
encapsulated compounds.  
 
 
Keywords 
Amaranth protein isolate, pullulan, encapsulation, electrospinning, quercetin, ferulic 
acid, in-vitro digestion, controlled release 
Chemical compounds studied in this article 
Quercetin (PubChem CID: 5280343); Ferulic acid (PubChem CID: 445858)  
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1. Introduction 
Synthetic antioxidants are often used to preserve food quality, although natural 
antioxidants like carotenoids, vitamins, flavonoids and phenolic acids act as a natural 
defense in the organism to fight illnesses. In particular, food antioxidants have focused a 
great deal of attention due to their potential to prevent certain diseases like cancer and 
neurodegenerative or cardiovascular diseases (Giampieri, Alvarez-Suarez, & Battino, 
2014; Mates, Segura, Alonso, & Marquez, 2011; Yang et al., 2013).  
Quercetin is a flavonoid naturally present in vegetables, fruits, non-alcoholic drinks and 
medicinal plants. It is abundant in apples, onions, teas and red wines, where it is present 
as a glucoside. Many health-related beneficial effects have been ascribed to quercetin, 
including anti-inflammatory and antiallergic effects as well as having the potential to 
diminish or prevent cardiovascular disease and certain types of cancer (Campbell et al., 
2006; Fawzy & Asker, 2009; Gupta et al., 2010; Makris & Rossiter, 2001). The 
limitations for incorporating quercetin into functional foods are related to its low water 
solubility, as well as its degradation when exposed to high temperature, oxygen and/or 
light (Buchner et al., 2006; Scalia & Mezzena, 2009; Zenkevich et al., 2007). 
Furthermore, its low bioavailability as well as the chemical instability when exposed to 
gastrointestinal track conditions, limits the biological activity and therefore the potential 
health benefits. 
Ferulic acid is a hydroxycinnamic acid, with strong antioxidant properties. It is an 
abundant phenolic compound found in plant cell walls, but it is barely present as a free 
compound, but usually it is covalently bound to polysaccharides or proteins from the 
cell walls. In its free form, ferulic acid is a potent antimicrobial compound (Jeong et al., 
2000) and has demonstrated to be a chemopreventive agent towards colon cancer 
(Kawabata et al., 2000). Ferulic acid is FDA approved and, among other uses, it is 
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added as a preservation agent to inhibit autooxidation of oils (Graf, 1992). Its 
drawbacks for direct addition to functional foods are the photodegradation and 
sensitivity to oxygen exposure. 
 
Micro- and nanoencapsulation have been considered as plausible options for the 
protection of these antioxidant compounds (Braithwaite et al., 2014). For instance, 
Scalia et al. (2009) demonstrated that incorporating quercetin within lipidic 
microparticles effectively resulted in lower photodegradation of the bioactive. Similarly, 
the development of nanoencapsulation systems based on ciclodextrins, liposomes and 
quitosan have resulted efficient in improving the solubility, stability and bioavailability 
of quercetin in pharmaceutical applications (Barras et al., 2009; Wu et al., 2008; Zhang 
et al., 2007). Pool et al. (2012a & 2012b) developed PLGA and Eudragit nanoparticles 
loaded with quercetin, proving that the antioxidant activity and the biaccessibility 
within simulated small intestinal conditions were enhanced when quercetin was 
encapsulated. Quercetin has also been incorporated in nanoemulsion-based delivery 
systems improving its bioaccessibility compared with crystalline quercetine (Pool et al., 
2013).  Similarly, encapsulation systems for ferulic acid based on cyclodextrins, lipidic 
nanoparticles, micelles, and microemulsions have been developed (Anselmi et al., 2008; 
Carlotti et al., 2008). 
Regarding the encapsulation techniques, in the last years, electrospinning has been 
broadly explored as a straightforward and versatile method, with a number of 
advantages when compared to traditional encapsulation techniques such as spray drying, 
coacervation or ionic gelation (Bhushani & Anandharamakrishnan, 2014; Zussman, 
2011). In fact, this high-voltage-based technique has been recently used to develop 
electrospun fibres containing quercetin (Li et al., 2014; Peng et al., 2011) and ferulic 
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acid (Yan et al., 2014; Yu et al., 2010). However, even though during the process of 
fibre formation is normally considered that the solvent is mostly evaporated, for food-
related applications it is highly desired that food-derived matrices and food-approved 
solvents are used for encapsulation. Recently, we reported about the development of 
novel amaranth protein-based electrospun fibres using a food contact solvent (Aceituno-
Medina et al., 2013). Amaranth is a traditional under-utilized Mexican crop with highly 
nutritious grains and leafs. The aim of this work was to investigate the potential of these 
novel amaranth-based structures for the encapsulation and protection of two potent 
antioxidant compounds (quercetin and ferulic acid) to be incorporated into functional 
foods. To the best of our knowledge, this is the first time that an amaranth protein-based 
matrix is used for the encapsulation and protection of bioactives. The morphology of the 
developed electrospun fibres together with the encapsulation efficiency and bioactive 
stability and distribution within the fibres were studied. Moreover, the release profile 
and antioxidant capacity of the encapsulated functional substances during an in-vitro 
digestion study were also investigated and compared to that of the free compounds. 
 
2. Materials and methods 
2.1 Materials 
Formic acid of 95% purity, the non-ionic surfactant polyoxyethylene sorbitan 
monooleate (Tween 80), quercetin, ferulic acid (99.98% of purity), 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS), potassium persulphate and pullulan 
(Mw~100,000 Da) were supplied by Sigma-Aldrich (St. Louis, MO, USA). All products 
were used as received, without further purification. The commercial amaranth protein 
concentrate (Amaranthus hypochondriacus L. Revancha variety) was supplied by 
Nutrisol (Hidalgo, Mexico). The Amaranth Protein Isolate (API) was prepared based on 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
the methodology previously reported by Martínez and Añón (1996) with some 
modifications. The protein isolate prepared under these conditions consisted in a 
mixture of different proteins with molecular weights ranging from 10-83 kDa 
(Aceituno-Medina et al., 2013). Briefly, the commercial amaranth protein concentrate 
(APC) was defatted with hexane for 12 h (10% (w/v) suspension). Then, the amaranth 
protein concentrate was suspended in water and its pH was adjusted to 9 with a 2 M 
NaOH solution. The suspension was stirred for 30 min at room temperature and, then, 
centrifuged 20 min at 9000 g. Then, the supernatant was adjusted to pH 5 with 2 M HCl 
and centrifuged at 9000 g for 20 min at 4°C. The pellet was resuspended in water, 
neutralized with 0.1 N NaOH and freeze-dried. The protein content was determined by 
the Kjeldahl technique (AOAC, 1996) using a conversion factor of 5.85.  
 
2.2 Preparation of bioactive-containing solutions for electrospinning 
In order to develop the electrospun fibres for encapsulation of the bioactives, blends of 
50:50 (w/w) and 80:20 (w/w) API:pullulan blends with the surfactant Tween 80 (~20 % 
by weight with respect to the API content) were prepared using 95% formic acid as the 
solvent. The polymer content in solution was kept constant at 20% (w/v). The bioactives 
were incorporated in the solutions at 10 % (w/w) in the case of quercetin and 20% 
(w/w) in the case of ferulic acid with respect to the biopolymer blend weight. The 
solutions were gently stirred until homogeneous dispersions were obtained. 
 
2.3 Characterization of the polymer solutions 
The apparent viscosity (a) of the polymeric solutions at 100 s
-1 
was determined using a 
rotational viscosity meter Visco Basic Plus L from Fungilab S.A. (San Feliu de 
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Llobregat, Spain) using a Low Viscosity Adapter (LCP). The measurements were made 
in triplicate at 25ºC. 
 
2.4 Development of encapsulation structures through electrospinning 
The methodology to obtain API/pullulan fibres through electrospinning has been 
described elsewhere (Aceituno-Medina et al., 2013). All of the electrospinning 
experiments were carried out at room temperature in air. The electrospinning 
environmental conditions were maintained stable at 24°C and 60% RH by having the 
equipment enclosed in a specific chamber with temperature and humidity control. In 
this work, the specific conditions of the electrospinning process for obtaining the fibres 
loaded with the bioactives were: a tip-to-collector distance of 10 cm, a flow rate of the 
solution of 0.4 ml/h and the voltage was kept at 22 kV. 
 
2.5 Optical and Scanning Electron Microscopy (SEM) 
The presence and distribution of the bioactives within the electrospun API/pulllulan 
fibres were observed using a digital microscopy system (Nikon Eclipse 90i, Barcelona, 
Spain) fitted with a 12 V, 100 W halogen lamp and equipped with a digital imaging 
head which integrates an epifluorescence illuminator. A digital camera head (Nikon DS-
5Mc) with a 5 megapixel CCD cooled with a Peltier mechanism was attached to the 
microscope. Nis Elements software (Nikon Instruments Inc., Melville, NY, USA) was 
used for image capturing and the Adobe Photoshop CS3 extended software was used for 
image processing and analysis.  
The morphology of the bioactive-containing electrospun fibres was examined using 
SEM (Hitachi S-4100) after sputtering the samples with a gold–palladium mixture 
under vacuum. All SEM experiments were carried out at an accelerating voltage of 10 
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kV. Fibre diameters of the electrospun fibres were measured by means of the Adobe 
Photoshop 7.0 software from the SEM micrographs in their original magnification. 
 
2.6 Raman microspectroscopy  
The dispersion of the bioactives within the electrospun fibres were analyzed using 
Raman microspectroscopy. Raman images were taken with a Jasco NRS-3100 Confocal 
Micro- Raman spectrophotometer (Jasco Inc., Easton, MD, USA) using a short working 
distance 100x objective. The laser source used was a NIR excitation tuned at 785 nm to 
avoid excessive fluorescence in the Raman signal. Raman chemical images were carried 
out in the point by point mode by plotting the areas of the quercetin and ferulic acid 
bands at 1322 and 1606 cm-1, respectively, and were constructed by taking 25 x 25 
spectra equally spaced along the selected fibre sample area. Both bioactives are good 
Raman scatterers and, thus, very short acquisition times (i.e. 2-3 s) were needed to 
record intense spectra, which only showed the signal of the antioxidants within the 
electrospun fibres.  
 
2.7 Encapsulation efficiency 
To assess the bioactive encapsulation yield, approximately 3 mg of loaded fibres were 
placed in a Falcon tube with 5 ml of ethanol and stirred during 10 min at 300 rpm to 
remove the bioactive from the surface of the encapsulation structures. Then, the tubes 
were centrifuged at 10000 g during 10 min at 20ºC. The supernatant was taken and 
stored for subsequent analysis and the precipitate was repeatedly resuspended in 5 ml of 
ethanol and centrifuged as explained above until no signal from the bioactive was 
obtained. The amount of quercetin and ferulic acid was monitored through UV-Vis 
spectrophotometry using a SP-2000UV spectrophotometer, through interpolation of the 
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absorbance maximum at 256 nm and 324 nm for quercetin and ferulic acid, 
respectively, within the calibration curves previously obtained.  
 
2.8 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis (TG) curves were recorded with a TGA-DTA Setaram 
Setsys equipment. The samples (ca. 10 mg) were heated from 50 to 800°C with a 
heating rate of 5°C/min under argon atmosphere.  
 
2.9 Release kinetics during in-vitro digestion 
The in-vitro digestion studies were carried out following the methodology proposed by 
Dinnella et al. (2007). For the gastric digestion, 4mg of fibres (10 tubes with 4 mg of 
sample each) were diluted with 5 ml of distilled water and acidified to pH 2 using 6M 
HCl under constant stirring. Later on, 0.6 ml of a porcine pepsin solution (160 mg/ml) 
in 0.1 M HCl were added to the previous solution; distilled water was added to reach a 
final volume of 10 ml. The mixture was protected from light and stirred for 2h at 37ºC. 
At different time intervals (10, 30, 60, 90 and 120 min) the amount of released bioactive 
was analyzed through UV-Vis spectrophotometry. The amount of released bioactive 
was calculated from the previously developed calibration curve. After gastric digestion, 
the pH of the digesta was increased to pH 5 with 0.045 M NaHCO3 and 2.4 ml of 
pancreatin–bile solution (pancreatin 4 mg/ml, bile 25 mg/ml in 0.1 M NaHCO3) were 
added. Then, the pH was increased to 7.0 with 0.005 M NaHCO3, and the mixture, 
protected from light, was stirred at 37 °C for 2 h. Similarly as in the gastric stage, the 
released bioactive was analyzed at different time intervals (10, 30, 60, 90 and 120 min) 
through UV-Vis spectrophotometry following the same methodology as described 
above. 
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2.10 Antioxidant activity during in-vitro digestion 
The antioxidant activity was quantified along the digestion process to assess the 
protective effect of the encapsulation structures developed. The antioxidant capacity 
was determined using the ABTS
●+
 radical cation method (Re et al., 1999) using Trolox 
in methanol as a standard. The measurements were carried out at 734 nm using a 96 
well microplate reader (Molecular Devices Inc, Sunnyvale, CA, U.S.A.). Results are 
expressed as mmol Trolox equivalent antioxidant activity/g of bioactive.  
The in-vitro digestion process was carried out following the same methodology as 
above, but in this case, 20 mg of fibres and the equivalent amount of free bioactive 
solubilized in ethanol were used. The methanolic extracts obtained after the gastric and 
intestinal stages were homogeneized and 20 µl of these solutions were added to 230 µl 
of the ABTS
●+
 solution (absorbance of 0.7± 0.02). 
The inhibition percentages were calculated using equation 1. A decrease in the 
characteristic blue colour of the radical ABTS
●+
 upon bioactive reaction provides a 
measurement of the capacity that this compound has to stabilize the radical. This change 
in colour is indicated by a decrease in the absorbance maximum at 734 nm: 
% inhibition = [(Abs control – Abs sample)/Abs control]* 100  (Eq. 1) 
The equivalent Trolox antioxidant capacity (TEAC) of the different compounds after 
the in-vitro gastric and intestinal digestion processes was calculated taking into account, 
both the bioactive content of the fibres and the release percentage at the end of the 
gastric and intestinal digestion stages. 
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3. RESULTS AND DISCUSSION 
3.1 Morphology of the encapsulation structures and distribution of the bioactives within 
the fibres 
In a previous work, electrospun fibres made of an amaranth protein isolate (API) and 
pullulan in different concentrations were developed and it was found that up to 80% 
(w/w) API content, when the surfactant Tween 80 (~20 % by weight with respect to the 
API content) was added, continuous and relatively homogeneous fibres were obtained 
(Aceituno-Medina et al., 2013). Initially, the effect of bioactive incorporation within the 
electrospun fibres was studied and related to the viscosity of the initial solutions. The 
amount of bioactive that could be added to the electrospinning solutions giving raise to 
stable suspensions and, thus, to a continuous fibre production process was first 
optimized. Regarding quercetin incorporation, only the solutions with the composition 
50:50 API:pullulan (w/w) were suitable for stable electrospinning with a maximum 
bioactive content of 10 % by weight with respect to the biopolymer blend weight. In the 
case of ferulic acid, it was possible to incorporate this antioxidant within the fibres with 
more API content, i.e. in the 80:20 (w/w) API:pullulan structures, and the maximum 
loading attained was 20 % (w/w). Greater loadings resulted in precipitation of ferulic 
acid. Therefore, these two compositions were selected for subsequent analysis. 
As observed in Figure 1, addition of quercetin to the API:pullulan fibres did not 
significantly modify the viscosity of the solution, but resulted in average thinner 
diameters of the electrospun fibres. This result indicates that, probably, addition of 
quercetin resulted in increased conductivity of the solution, which is known to affect the 
whipping motion of the electrospinning jet, thus, leading to thinner fibres (Bhardwaj & 
Kundu, 2010). In the case of ferulic acid addition, a slight increase in solution viscosity 
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was observed, which is usually related to thicker fibre morphologies (Suwatong et al., 
2007). In general, for both encapsulation structures, smooth and defect-free fibres were 
obtained, confirming that no phase separation occurred during the electrospinning 
process and suggesting a good dispersion of the bioactives.  
 
INSERT FIGURE 1 ABOUT HERE 
 
In order to confirm the effective encapsulation of the antioxidants, fluorescence optical 
microscopy was carried out. Quercetin is known to have an emission fluorescence 
wavelength between 500 and 600 nm (Ram et al., 2004; Sengupta y Sengupta, 2003), 
while ferulic acid exhibits an emission at approximately 425 nm (Ram et al., 2004) and, 
thus, this property was used to visually check the inclusion of the antioxidants within 
the electrospun structures. Figure 1 also shows the fluorescence images of the 
API:pullulan fibres containing both bioactives which, as observed, seemed to be well 
distributed along the fibres. 
Raman spectroscopy was also used to evaluate, not only the distribution, but also the 
stability of the encapsulated compounds. First, the Raman spectra of both compounds 
was obtained, so as to identify the characteristic vibrational bands with the aim to 
construct the Raman images from the confocal microscopy images taken from the 
samples. Figure 2 shows both the individual Raman spectra from the bioactives and the 
corresponding confocal Raman images from the API:pullulan electrospun fibres 
containing the antioxidants, which were obtained considering the area of the 
characteristic vibrational bands from quercetin and ferulic acid at 1322 cm-1 and 1606 
cm
-1
, respectively. 
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INSERT FIGURE 2 ABOUT HERE 
 
The Raman images confirmed that as inferred from the fluorescence microscopy 
images, the bioactives were evenly distributed along the fibres. From Figure 2 it seems 
that some agglomeration areas were present in the quercetin-containing structures, fact 
that could be also observed in the fluorescence image (cf. Figure 1E). However, no 
displacements were observed in the vibrational bands from the individual spectra taken 
from the Raman images, indicating that the encapsulation process itself did not affect 
the stability of the bioactive compounds. It is interesting to note that even in the image 
points of lower intensity (indicated in the Raman images as F and G for the quercetin 
and ferulic acid structures, respectively), some characteristic bands from the 
antioxidants could be discerned, again highlighting the good dispersion of the bioactives 
within the encapsulates. 
 
3.2 Encapsulation efficiency 
To evaluate the encapsulation efficiency, calibration curves from both antioxidants in 
ethanol were prepared. The amount of quercetin and ferulic acid within the developed 
API:pullulan electrospun fibres was then monitored through UV-Vis spectrophotometry 
through interpolation of the absorbance maximum at 256 and 324 nm for quercetin and 
ferulic acid, respectively, within the calibration curves previously obtained. Both the 
equations for the calibration curves and the encapsulation efficiency are compiled in 
Table 1. 
 
INSERT TABLE 1 ABOUT HERE 
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From this table it can be observed that very good encapsulation yields were obtained for 
both bioactives in comparison with other encapsulation technologies (Barras et al., 
2009; Zhang et al., 2008). The efficiency obtained for quercetin was higher, but it 
should be taken into account that the concentration of bioactive in this case was half the 
concentration of ferulic acid used. 
 
3.3 Thermal stability of the encapsulation structures 
Thermogravimetric analysis of the loaded encapsulation structures was carried out to 
investigate if the encapsulation process affected the thermal stability of both the 
antioxidants and the matrices. Table 2 summarizes the main results and includes the 
data for the bioactives alone and for the encapsulation structures without the bioactives 
for comparison purposes. Pure quercetin displayed two main degradation events with 
maximums at ca. 91ºC and 358ºC. The first one is related to water loss of the 
compound, which disappeared upon encapsulation. The temperature of the second 
degradation peak, which corresponds to the degradation temperature of this flavonoid, 
significantly decreased upon encapsulation down to 220ºC, probably due to the 
dissolution/dispersion of the bioactive before encapsulation. Similar results of decreased 
thermal stability were observed upon complexation of quercetin with gelatinized starch 
(Zhang et al., 2011). However, it should be noted that the degradation temperature 
within the capsules is still far from the usual temperatures used for food processing.  
 
INSERT TABLE 2 ABOUT HERE 
 
Regarding ferulic acid, a single degradation event was seen for the pure compound at 
210ºC. In a similar way as with quercetin, upon encapsulation within the electrospun 
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fibres, the degradation peak maximum temperature decreased to 177ºC. The other two 
degradation peaks observed when plotting the weight loss first derivate from the TGA 
curves of the encapsulation structures at 300 and 400ºC corresponded to the 
degradation of the API:pullulan blend and to the surfactant Tween 80, respectively 
(Aceituno-Medina et al., 2013). When comparing these maximums with those from the 
structures without bioactive, a slight decrease in the degradation temperature from the 
biopolymer blend was observed, while the degradation temperature of the surfactant 
remained almost unchanged (cf. Table 2). 
 
3.4 Release kinetics of the bioactives during in-vitro digestion 
It is important to understand how the bioactives are released from the encapsulation 
structures during the process of digestion along the gastrointestinal (GI) tract when 
exposed to different pH conditions and to the presence of enzymes. It has been reported 
that micro and nanostructured systems as well as hydrogels shrink in gastric conditions 
while they swell under intestinal conditions, fact that conditions the release of the 
encapsulated bioactive substances (Chen et al., 2004; Hoad et al., 2009; Rayment et al., 
2009). 
In this work, following the in-vitro digestion methodology proposed by Dinnella et al. 
(2007), the amount of bioactives released from the API:pullulan structures during this 
simulated process was quantified. 
Figure 3 shows the release profiles for quercetin and ferulic acid. It can be observed that 
in the first 10 min of gastric digestion, 22 and 15% of quercetin and ferulic acid, 
respectively, were released from the electrospun fibres, which probably corresponded to 
the bioactive molecules closer to the fibre surface. These release mechanisms have been 
already described for sorgo and maize proteins (Taylor et al., 2009; Wang et al., 2005) 
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and are also related to the high specific surface of the ultrathin encapsulation structures. 
A sustained release of quercetin from the electrospun encapsulation structures was 
observed during the gastric stage, releasing 52% of the total compound. 
Comparatively, the release of ferulic acid during the gastric stage was quicker and 
almost 60% of the antioxidant was released in only 30 min. Yu et al. (2010) 
incorporated ferulic acid in polyvinyl pyrrolidone nanofibres adding SDS as anionic 
surfactant and quantified the release in PBS medium. They observed a complete release 
of the bioactive in the first 10 min and, thus, when comparing with the present results, a 
considerable improvement in the release characteristics was observed using the 
API:pullulan structures.  
 
INSERT FIGURE 3 ABOUT HERE 
 
At the beginning of the intestinal in-vitro digestion process, another quick increase in 
the release profiles was observed for both bioactives (19 and 21% in the quercetin 
and ferulic acid release, respectively), which could be ascribed to the change in pH 
which probably affected the conformation of the amaranth protein encapsulating matrix, 
facilitating the release of the antioxidant s. Similar results have been reported for 
catechins encapsulated in protein-based matrices (Taylor et al., 2009). At the end of the 
in-vitro intestinal digestion stage, the amount of quercetin and ferulic acid released 
corresponded to 82 and 99% of the total content within the fibres, respectively. 
In general, a more sustained release of quercetin was observed, which was probably 
related not only to the different composition of the fibres (i.e. ratio between API and 
pullulan and bioactive concentration), but also to the interactions of the bioactives 
themselves with the encapsulating matrices. 
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3.5 Antioxidant capacity of encapsulated vs. free bioactives during in-vitro digestion 
It is well-known that pH and exposure to light, oxygen and temperature, may diminish 
the antioxidant activity of nutraceutical compounds (Liang y Subirade, 2010; Sansone et 
al., 2011; Anselmi et al., 2008; Carlotti et al., 2008; Fernández et al., 2009). However, 
little is known about how this antioxidant activity is kept during the digestion process. 
Therefore, a further aim of the present study was to evaluate the antioxidant activity of 
the encapsulated bioactives after the in-vitro digestion study and to compare it with that 
from the non-encapsulated compounds. The ABTS
●+
 method has been widely employed 
for evaluation of the antioxidant activity of biological materials, pure compounds and 
plant extracts both from hydrophilic and lipophilic nature. The inhibition percentage 
represents the loss of blue-green colour of the radical ABTS
●+
, upon addition of the 
antioxidant, thus decreasing the absorbance values measured at 734 nm. The control 
samples used to evaluate the antioxidant activity loss were freshly prepared methanolic 
extracts of the bioactives at the same concentrations than those found in the fibres. 
Moreover, the antioxidant activity of the pure fibres (without bioactive) and of the 
enzymes employed in the in-vitro digestion process were also analysed, so as to check if 
they also contributed to the antioxidant activity recorded. 
For the calibration curve, different concentrations of Trolox were prepared (from 50 to 
800 mM) and the inhibition percentage for each of the concentrations was calculated, 
obtaining the following calibration curve equation: 
y= 25.176x + 3.9357   R
2
 = 0.9925 (Eq. 2) 
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The equivalent Trolox antioxidant capacity (TEAC) of the different compounds after 
the in-vitro gastric and intestinal digestion processes was calculated and the results are 
compiled in Table 3.  
 
INSERT TABLE 3 ABOUT HERE 
 
It is important to highlight that the TEAC for the encapsulated bioactives was calculated 
taking into account, both the bioactive content of the fibres and the release percentage at 
the end of the gastric and intestinal digestion stages. As commented on above, initially, 
the antioxidant capacity of the pure bioactives was evaluated, providing inhibition 
percentages of 48.12 and 52.17% for the quercetin and ferulic acid, respectively. 
From Table 3, it can be observed that the inhibition percentage obtained from the neat 
fibres and the enzymes used in the in-vitro digestion process was low in comparison 
with that from the bioactives, indicating that they did not have a relevant antioxidant 
capacity. Nevertheless, the obtained values were substracted from their respective 
systems, so as not to overestimate the antioxidant capacity of both the free and 
encapsulated bioactives. From these corrected values in Table 3, it is clearly observed 
that the conditions used during the in-vitro digestion process, effectively affected the 
antioxidant capacity of the non-encapsulated bioactives and more than 60 and 70% of 
the initial inhibition percentage obtained for the quercetin and ferulic acid, respectively, 
was loss at the end of the digestion process. In contrast, encapsulation of the bioactives 
within the API:pullulan electrospun encapsulation structures resulted in an effective 
protection for the antioxidant capacity, showing inhibition percentajes of the radical 
ABTS
●+
 which doubled those from the non-encapsulated compounds. These results are 
promising since they show the ability of these API:pullulan fibres to protect quercetin 
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and ferulic acid during the in-vitro digestion, keeping to a greater extent their 
antioxidant capacity. 
 
4. CONCLUSIONS 
Quercetin and ferulic acid were properly encapsulated within amaranth protein isolate 
(API):pullulan ultrathin fibres using the electrospinning technique. The composition of 
the fibres was optimized and smooth, defect free encapsulation structures were obtained 
which contained the antioxidants evenly distributed along the fibres. The thermal 
stability of the bioactives decreased upon encapsulation, probably due to the 
dissolution/dispersion of the antioxidants required for subsequent electrospinning. 
However, a sustained release of quercetin and ferulic acid from the API:pullulan 
electrospun fibres was observed during in-vitro digestion, fact which contributed to 
improved antioxidant capacity of the bioactives in comparison with the free compounds. 
Therefore, the developed electrospun structures show promisory results in terms of 
bioactive protection for application in functional foods. 
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Table 1. UV-Vis calibration curve equations and encapsulation efficiencies for 
quercetin and ferulic acid incorporated within 50:50 and 80:20 Amaranth Protein 
Isolate:pullulan electrospun fibers, respectively. 
 
Bioactive Wt.% 
Calibration curve 
equation 
Theoretical 
concentration 
(µg bioactive/mg 
fiber) 
Real 
concentration 
(µg bioactive/mg 
fiber) 
Encapsulation 
efficiency  
(%) 
Quercetin 10 
 
y = 0.0072x + 0.0211 
R
2
= 0.988 
 
83.3 78.1 ± 0.1 93.6 ± 0.1 
Ferulic 
acid 
20 
 
y = 0.0090x + 0.0014 
R
2
= 0.998 
 
 
147.1 
 
 
123.1 ± 0.2 
 
83.7± 0.1 
Table 1
Table 2. TGA maximums of the weight loss first derivate (TD) for the different 
encapsulation structures 
Bioactive API:pullulan 
(bioactive) 
Tmax1 
(ºC) 
Tmax2 
(ºC) 
Tmax3 
(ºC) 
- 50:50 –
* 
 306.9 401.1 
80:20 –*  310.9 407.3 
Quercetin - (100%) 90.9 357.8  
50:50 (10%) 220.6 298.6 403.4 
Ferulic acid - (100%) 210.7   
80:20 (20%) 177.26 306.8 406.3 
* Reference: Aceituno-Medina et al. (2013) 
Table 2
Table 3. Inhibition % of the ABTS radical and Trolox equivalent antioxidant capacity 
(TEAC) for the electrospun fibers, pure bioactives and enzymes studied after in-vitro 
gastric and intestinal digestion. 
Sample 
Gastric Conditions Intestinal Conditions 
Inhibition % 
TEAC  
(mmol Trolox/g 
bioactive) 
Inhibition % 
TEAC  
(mmol Trolox/g 
bioactive) 
API:pullulan 50:50 3.52 ± 0.03 - 4.85 ± 0.03  - 
API:pullulan 80:20 5.09 ± 0.01 - 8.98 ± 0.01 - 
Quercetin 13.39 ± 0.01 4.65 ± 0.01 16.62 ± 0.04 7.90 ± 0.02 
API:pullulan (Quercetin) 30.12 ± 0.26 24.56 ± 0.24 31.06 ± 0.12 19.63 ± 0.09 
Ferulic acid 17.56 ± 0.15 3.87 ± 0.04 14.96 ± 0.09 3.96 ±0.03 
API:pullulan (Ferulic acid) 37.69 ± 0.67 15.16 ± 0.30 33.89 ± 0.20 10.43 ± 0.71 
Enzymes 2.56 ± 0.01 - 8.41 ± 0.01 - 
 
Table 3
Figure Captions 
 
Figure 1. SEM (A-D) and fluorescence microscopy (E,F) images of: 50:50 (A, C, E) 
and 80:20 (B,D,F) API:pullulan fibers without bioactive (A, B) and containing 10wt.% 
quercetin (C, E) and 20wt.% ferulic acid (D,F). Scale markers correspond to 1 µm (C), 
2µm (A, B, D) and 10 µm (E, F). SEM micrographs include the apparent viscosity 
(
app
) of the solutions and average diameter of the fibers obtained. 
 
Figure 2. Individual Raman spectra of pure quercetin (A) and ferulic acid (B) and 
confocal Raman images of API:pullulan electrospun fibers containing quercetin (C) and 
ferulic acid (D) with the corresponding individual Raman spectra defined in the images 
as E, F, G and H.  
 
Figure 3. Release kinetics of (A) quercetin and (B) ferulic acid from the API:pullulan 
fibers during an in-vitro digestion study. 
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